Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands.

Brandl K, Sun L, Neppl C, Siggs OM, Le Gall SM, Tomisato W, Li X, Du X, Maennel DN, Blobel CP, Beutler B.

Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):19967-72. doi: 10.1073/pnas.1014669107. Epub 2010 Nov 1.

2.

Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injury.

Hsu D, Fukata M, Hernandez YG, Sotolongo JP, Goo T, Maki J, Hayes LA, Ungaro RC, Chen A, Breglio KJ, Xu R, Abreu MT.

Lab Invest. 2010 Sep;90(9):1295-305. doi: 10.1038/labinvest.2010.100. Epub 2010 May 24.

3.

EGF-like growth factors induce COX-2-derived PGE2 production through ERK1/2 in human granulosa cells.

Fang L, Cheng JC, Chang HM, Sun YP, Leung PC.

J Clin Endocrinol Metab. 2013 Dec;98(12):4932-41. doi: 10.1210/jc.2013-2662. Epub 2013 Oct 3.

PMID:
24092824
4.

Mammary tumorigenesis induced by fibroblast growth factor receptor 1 requires activation of the epidermal growth factor receptor.

Bade LK, Goldberg JE, Dehut HA, Hall MK, Schwertfeger KL.

J Cell Sci. 2011 Sep 15;124(Pt 18):3106-17. doi: 10.1242/jcs.082651. Epub 2011 Aug 24.

5.

Regulation of colonic epithelial repair in mice by Toll-like receptors and hyaluronic acid.

Zheng L, Riehl TE, Stenson WF.

Gastroenterology. 2009 Dec;137(6):2041-51. doi: 10.1053/j.gastro.2009.08.055. Epub 2009 Sep 2.

7.

Cross-suppression of EGFR ligands amphiregulin and epiregulin and de-repression of FGFR3 signalling contribute to cetuximab resistance in wild-type KRAS tumour cells.

Oliveras-Ferraros C, Cufí S, Queralt B, Vazquez-Martin A, Martin-Castillo B, de Llorens R, Bosch-Barrera J, Brunet J, Menendez JA.

Br J Cancer. 2012 Apr 10;106(8):1406-14. doi: 10.1038/bjc.2012.103.

8.

Cathelicidin signaling via the Toll-like receptor protects against colitis in mice.

Koon HW, Shih DQ, Chen J, Bakirtzi K, Hing TC, Law I, Ho S, Ichikawa R, Zhao D, Xu H, Gallo R, Dempsey P, Cheng G, Targan SR, Pothoulakis C.

Gastroenterology. 2011 Nov;141(5):1852-63.e1-3. doi: 10.1053/j.gastro.2011.06.079. Epub 2011 Jul 14.

9.

Epiregulin-dependent amphiregulin expression and ERBB2 signaling are involved in luteinizing hormone-induced paracrine signaling pathways in mouse ovary.

Kim K, Lee H, Threadgill DW, Lee D.

Biochem Biophys Res Commun. 2011 Feb 11;405(2):319-24. doi: 10.1016/j.bbrc.2011.01.039. Epub 2011 Jan 13.

PMID:
21237132
10.

The role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasia.

Hernandez Y, Sotolongo J, Breglio K, Conduah D, Chen A, Xu R, Hsu D, Ungaro R, Hayes LA, Pastorini C, Abreu MT, Fukata M.

BMC Gastroenterol. 2010 Jul 16;10:82. doi: 10.1186/1471-230X-10-82.

11.

MyD88 adaptor-like (Mal) regulates intestinal homeostasis and colitis-associated colorectal cancer in mice.

Aviello G, Corr SC, Johnston DG, O'Neill LA, Fallon PG.

Am J Physiol Gastrointest Liver Physiol. 2014 May 1;306(9):G769-78. doi: 10.1152/ajpgi.00399.2013. Epub 2014 Mar 6.

12.

Paracrine and autocrine regulation of epidermal growth factor-like factors in cumulus oocyte complexes and granulosa cells: key roles for prostaglandin synthase 2 and progesterone receptor.

Shimada M, Hernandez-Gonzalez I, Gonzalez-Robayna I, Richards JS.

Mol Endocrinol. 2006 Jun;20(6):1352-65. Epub 2006 Mar 16.

PMID:
16543407
13.

Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx.

Horiuchi K, Le Gall S, Schulte M, Yamaguchi T, Reiss K, Murphy G, Toyama Y, Hartmann D, Saftig P, Blobel CP.

Mol Biol Cell. 2007 Jan;18(1):176-88. Epub 2006 Nov 1. Erratum in: Mol Biol Cell. 2010 Jun;21(11):1908.

14.

Adiponectin deficiency protects mice from chemically induced colonic inflammation.

Fayad R, Pini M, Sennello JA, Cabay RJ, Chan L, Xu A, Fantuzzi G.

Gastroenterology. 2007 Feb;132(2):601-14. Epub 2006 Nov 18.

PMID:
17258715
15.

Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin.

Sternlicht MD, Sunnarborg SW, Kouros-Mehr H, Yu Y, Lee DC, Werb Z.

Development. 2005 Sep;132(17):3923-33. Epub 2005 Aug 3. Erratum in: Development. 2006 Mar;133(6):1203.

16.

Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands.

Sahin U, Weskamp G, Kelly K, Zhou HM, Higashiyama S, Peschon J, Hartmann D, Saftig P, Blobel CP.

J Cell Biol. 2004 Mar 1;164(5):769-79.

17.

Amphiregulin exosomes increase cancer cell invasion.

Higginbotham JN, Demory Beckler M, Gephart JD, Franklin JL, Bogatcheva G, Kremers GJ, Piston DW, Ayers GD, McConnell RE, Tyska MJ, Coffey RJ.

Curr Biol. 2011 May 10;21(9):779-86. doi: 10.1016/j.cub.2011.03.043. Epub 2011 Apr 21.

18.

Human chorionic gonadotropin-dependent up-regulation of epiregulin and amphiregulin in equine and bovine follicles during the ovulatory process.

Sayasith K, Lussier J, Doré M, Sirois J.

Gen Comp Endocrinol. 2013 Jan 1;180:39-47. doi: 10.1016/j.ygcen.2012.10.012. Epub 2012 Nov 21.

PMID:
23178756
19.

ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis.

Révillion F, Lhotellier V, Hornez L, Bonneterre J, Peyrat JP.

Ann Oncol. 2008 Jan;19(1):73-80. Epub 2007 Oct 24.

PMID:
17962208
20.

A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis.

Ungaro R, Fukata M, Hsu D, Hernandez Y, Breglio K, Chen A, Xu R, Sotolongo J, Espana C, Zaias J, Elson G, Mayer L, Kosco-Vilbois M, Abreu MT.

Am J Physiol Gastrointest Liver Physiol. 2009 Jun;296(6):G1167-79. doi: 10.1152/ajpgi.90496.2008. Epub 2009 Apr 9.

Supplemental Content

Support Center